STEPHANIE BRISON: Open Payments
NPI 1205408242 · MANHATTAN, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$458 in 25 payments from 6 companies in 2025. Trend: 2023 $328 · 2024 $600 · 2025 $458
Food & beverage: $458
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 11 | $189 |
| ABBVIE INC. | 6 | $105 |
| Janssen Biotech, Inc. | 3 | $60 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $58 |
| Exact Sciences Corporation | 1 | $25 |
| VIVUS LLC | 1 | $20 |
Products named: ZENPEP, LINZESS, TREMFYA, XIFAXAN, CREON, Cologuard Collection Kit, PANCREAZE.
Industry payments across KS — which companies pay providers there.
